i-SENS, Inc. (KOSDAQ: 099190)

Market Cap	435.24B
Revenue (ttm)	284.77B
Net Income (ttm)	-1.83B
Shares Out	27.63M
EPS (ttm)	-66.41
PE Ratio	n/a
Forward PE	51.51
Dividend	100.00 (0.63%)
Ex-Dividend Date	Dec 27, 2024

Volume	71,605
Open	15,990
Previous Close	16,020
Day's Range	15,550 - 16,020
52-Week Range	14,520 - 30,400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 23, 2025

About i-SENS

i-SENS, Inc. engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally. The company offers blood glucose monitoring devices; diabetes care, acute care, and coagulation care devices; veterinary care devices; and accessory products. It also provides SmartLog, a diabetes management software for mobile and PC. The company was founded in 2000 and is headquartered in Seoul, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 845
• Stock Exchange: KOSDAQ
• Ticker Symbol: 099190

Financial Performance

In 2023, i-SENS's revenue was 265.12 billion, an increase of 0.11% compared to the previous year's 264.84 billion. Earnings were 3.71 billion, a decrease of -77.02%.